GB0008879D0 - Polypeptide delivery system - Google Patents
Polypeptide delivery systemInfo
- Publication number
- GB0008879D0 GB0008879D0 GBGB0008879.9A GB0008879A GB0008879D0 GB 0008879 D0 GB0008879 D0 GB 0008879D0 GB 0008879 A GB0008879 A GB 0008879A GB 0008879 D0 GB0008879 D0 GB 0008879D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- delivery system
- polypeptide delivery
- polypeptide
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0008879.9A GB0008879D0 (en) | 2000-04-12 | 2000-04-12 | Polypeptide delivery system |
PCT/SE2001/000799 WO2001076625A1 (en) | 2000-04-12 | 2001-04-09 | Iscom polypeptide delivery system |
AU2001248954A AU2001248954A1 (en) | 2000-04-12 | 2001-04-09 | Iscom polypeptide delivery system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0008879.9A GB0008879D0 (en) | 2000-04-12 | 2000-04-12 | Polypeptide delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0008879D0 true GB0008879D0 (en) | 2000-05-31 |
Family
ID=9889665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0008879.9A Ceased GB0008879D0 (en) | 2000-04-12 | 2000-04-12 | Polypeptide delivery system |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001248954A1 (en) |
GB (1) | GB0008879D0 (en) |
WO (1) | WO2001076625A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8919819D0 (en) * | 1989-09-01 | 1989-10-18 | Coopers Animal Health | Complexes having adjuvant activity |
SE9604296D0 (en) * | 1996-11-22 | 1996-11-22 | Astra Ab | New pharmaceutical formulation of polypeptides |
KR20010020418A (en) * | 1997-04-30 | 2001-03-15 | 마리에 폴린 에이로레 | Anti-Helicobacter vaccine composition comprising a Th1-type adjuvant |
AUPP807399A0 (en) * | 1999-01-08 | 1999-02-04 | Csl Limited | Improved immunogenic lhrh composition and methods relating thereto |
US7776343B1 (en) * | 1999-02-17 | 2010-08-17 | Csl Limited | Immunogenic complexes and methods relating thereto |
-
2000
- 2000-04-12 GB GBGB0008879.9A patent/GB0008879D0/en not_active Ceased
-
2001
- 2001-04-09 WO PCT/SE2001/000799 patent/WO2001076625A1/en active Application Filing
- 2001-04-09 AU AU2001248954A patent/AU2001248954A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001076625A1 (en) | 2001-10-18 |
AU2001248954A1 (en) | 2001-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0300246A3 (en) | Delivery system | |
AU1133002A (en) | Pesticide delivery system | |
GB0008494D0 (en) | Microprojectile delivery system | |
GB9904925D0 (en) | Gas delivery system | |
EP1225941A4 (en) | Intranasal delivery system | |
GB2347686B (en) | Gas delivery system | |
GB2352314B (en) | Delivery system | |
GB0015761D0 (en) | Polypeptide | |
GB0011066D0 (en) | Delivery system | |
GB0014898D0 (en) | Delivery system | |
GB9904695D0 (en) | Peptide | |
GB0029843D0 (en) | Drug delivery system | |
GB9914960D0 (en) | Delivery system | |
GB0008877D0 (en) | Polypeptide delivery system | |
GB0009251D0 (en) | Message delivery system | |
GB9908920D0 (en) | Peptide | |
GB0210014D0 (en) | Fuel delivery system | |
GB0008879D0 (en) | Polypeptide delivery system | |
GB0120704D0 (en) | Polypeptide | |
GB0101866D0 (en) | Fuel delivery system | |
GB0113857D0 (en) | Delivery system | |
GB0001935D0 (en) | Delivery system | |
GB0026332D0 (en) | Delivery system | |
GB2337520B (en) | Delivery system | |
GB0013239D0 (en) | Polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |